All In MedTech

Device Trial Radar · NCT07921784

Effects of IASTM, Deep Friction Massage, and Sham Instrument-Assisted Soft Tissue Mobilization on Electromyographical Activation, Pain and Function in Non-Specific Low Back Pain

Effects of Instrument-Assisted Soft Tissue Mobilization, Deep Friction Massage, and Sham Instrument-Assisted Soft Tissue Mobilization on Electromyographical Activation, Pain and Function in Non-Specific Low Back Pain

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

66

Planned (sponsor's estimate)

Start

Oct 15, 2026

Primary completion

Jun 15, 2027

Study completion Jun 15, 2027

Sponsor

Lead sponsor
Imam Abdulrahman Bin Faisal UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 6, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Background: Non-specific low back pain is a leading cause of global disability and physical, psychological, and socioeconomic burdens. While instrument-assisted soft tissue mobilization has shown benefits for pain, disability, and range of motion, it remains unclear whether these effects stem from the instrument itself, mobilization mechanisms, or placebo factors. Additionally, no prior study has directly compared it with deep friction massage. Objective: To compare the effects of instrument-assisted soft tissue mobilization, deep friction massage, and sham treatment on pain, disability, lumbar range of motion, pressure pain threshold, psychological status, and electromyographical activation in individuals with non specific low back pain. Methods: This trial will recruit 66 participants aged 18 to 60 years with chronic low back pain. Participants will be randomly assigned to one of three groups and receive a standardized four week rehabilitation program of two sessions per week, including hot packs, stretching, strengthening. Outcomes will be assessed at baseline, immediately after the first session, and after four weeks using pain intensity scales, disability indices, range of motion measurements, Page 2of 6 surface electromyography as primary outcome measures, and pressure pain thresholds, and psychological status evaluations as secondary. Conclusion: This study will provide evidence on the comparative effectiveness of these interventions, helping clarify the specific therapeutic value of instrument-assisted soft tissue mobilization.

Conditions

  • Low Back Pain
  • Trigger Point Pain, Myofascial

Interventions

  • Instrument Assisted Soft Tissue MobilizationDevice

    Patients in the IASTM group will be treated with the help of D shaped stainless-steel IASTM instruments with sweep and fan movements being made across the lumbar paraspinal muscles and adjacent myofascial structures under moderate pressure \[29\]. During the treatment, the area under work will be coated with a lubricant, while the tool will be used at a certain angle to the tissues (30°-60°)

  • Deep Friction MassageProcedure

    Participants in the DFM group will undergo manual deep transverse friction massage according to Cyriax \[25\] with deep pressure being applied across the fiber orientation of affected tissues using standardized rhythmic transverse movements, limited to only six sweeps.

  • Sham Instrument-Assisted Soft Tissue MobilizationDevice

    Placebo effect

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. painTime frame: Outcome measures will be collected at baseline before treatment initiation (T0), immediately after the first intervention session (T1), and at Week 4 following completion of the intervention period (T2).
  2. DisabilityTime frame: Outcome measures will be collected at baseline before treatment initiation (T0), and at Week 4 following completion of the intervention period (T2).
  3. Range of motionTime frame: Outcome measures will be collected at baseline before treatment initiation (T0), and at Week 4 following completion of the intervention period (T2).

1 more outcomes with a free account

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.